Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Supporting Patients Undergoing HIgh-Risk PCI Using a High-Flow PErcutaneous Left Ventricular Support Device (SHIELD II) (SHIELD II)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02468778
Recruitment Status : Suspended (Abbott has suspended enrollment of the SHIELD II IDE study after a report of decreased impeller speed at the end of a procedure.)
First Posted : June 11, 2015
Last Update Posted : March 16, 2021
Sponsor:
Information provided by (Responsible Party):
Abbott Medical Devices

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Suspended
Estimated Primary Completion Date : December 2021
Estimated Study Completion Date : December 2021